These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7695859)

  • 21. [-Tamoxifen and the endometrium: monitoring and evaluation of endometrial changes-].
    Rageth JC; Bronz L; Granberg S
    Arch Gynecol Obstet; 1995; 256 Suppl():S122-7. PubMed ID: 8619646
    [No Abstract]   [Full Text] [Related]  

  • 22. Association between CYP3A4 genotype and risk of endometrial cancer following tamoxifen use.
    Chu W; Fyles A; Sellers EM; McCready DR; Murphy J; Pal T; Narod SA
    Carcinogenesis; 2007 Oct; 28(10):2139-42. PubMed ID: 17434921
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Survival impact of tamoxifen use for breast cancer risk reduction: projections from a patient-specific Markov model.
    Col NF; Goldberg RJ; Orr RK; Erban JK; Fortin JM; Chlebowski RT
    Med Decis Making; 2002; 22(5):386-93. PubMed ID: 12365480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Significance of secondary ultrasonographic endometrial thickening in postmenopausal tamoxifen-treated women.
    Timmerman D; Neven P; Deprest J; Konstantinović ML; Vergote I
    Cancer; 2003 Jul; 98(2):431-2; author reply 432-3. PubMed ID: 12872366
    [No Abstract]   [Full Text] [Related]  

  • 25. Endometrial changes in post-menopausal breast cancer patients on tamoxifen.
    Al-Azemi M; Labib NS; Omu AE
    Int J Gynaecol Obstet; 2002 Oct; 79(1):47-9. PubMed ID: 12399095
    [No Abstract]   [Full Text] [Related]  

  • 26. Selective estrogen receptor modulation and reduction in risk of breast cancer, osteoporosis, and coronary heart disease.
    Jordan VC; Gapstur S; Morrow M
    J Natl Cancer Inst; 2001 Oct; 93(19):1449-57. PubMed ID: 11584060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tamoxifen (TAM): the dispute goes on.
    Grilli S
    Ann Ist Super Sanita; 2006; 42(2):170-3. PubMed ID: 17033137
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tamoxifen chemoprevention: public health goals, toxicities for all and benefits to a few.
    Love RR
    Ann Oncol; 1995 Feb; 6(2):127-8. PubMed ID: 7786819
    [No Abstract]   [Full Text] [Related]  

  • 29. Longitudinal hysteroscopic follow-up during tamoxifen treatment.
    Neven P; De Muylder X; Van Belle Y; Van Hooff I; Vanderick G
    Lancet; 1998 Jan; 351(9095):36. PubMed ID: 9433432
    [No Abstract]   [Full Text] [Related]  

  • 30. Tamoxifen for breast cancer prevention.
    Jordan VC
    Proc Soc Exp Biol Med; 1995 Feb; 208(2):144-9. PubMed ID: 7831346
    [No Abstract]   [Full Text] [Related]  

  • 31. The case for clinical trials of tamoxifen for prevention of breast cancer.
    Powles TJ
    Lancet; 1992 Nov; 340(8828):1145-7. PubMed ID: 1359221
    [No Abstract]   [Full Text] [Related]  

  • 32. Surveillance for endometrial cancer in postmenopausal breast cancer patients taking tamoxifen.
    Sinawat S; Chiyabutra T; Kleabkaew P
    Asian Pac J Cancer Prev; 2003; 4(4):327-30. PubMed ID: 14728591
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The current status of breast cancer chemoprevention: a star is born.
    Morrow M; Jordan VC
    J Surg Oncol; 2007 Jan; 95(1):4-5. PubMed ID: 17192883
    [No Abstract]   [Full Text] [Related]  

  • 34. Utilization of gynecologic services in women with breast cancer receiving hormonal therapy.
    Wright JD; Desai VB; Chen L; Burke WM; Tergas AI; Hou JY; Accordino M; Ananth CV; Neugut AI; Hershman DL
    Am J Obstet Gynecol; 2017 Jul; 217(1):59.e1-59.e12. PubMed ID: 28341383
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drugs can reduce the incidence of breast cancer: now what?
    Wozniak TF; Eppes PG; Wilson CT
    Del Med J; 1999 Sep; 71(9):387-9. PubMed ID: 10584440
    [No Abstract]   [Full Text] [Related]  

  • 36. Endometrial damage by antiestrogens in a postmenopausal breast cancer patient.
    Ceci O; Bettocchi S; Marello F; Pellegrino A; Impedovo L; Di Venere R
    Acta Obstet Gynecol Scand; 2002 Feb; 81(2):174-5. PubMed ID: 11942911
    [No Abstract]   [Full Text] [Related]  

  • 37. [Changes in the endometrium in treatment of breast carcinoma with tamoxifen].
    Reslová T; Tosner J; Vávrová I; Resl M
    Ceska Gynekol; 1997 Oct; 62(5):277-9. PubMed ID: 9600168
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MR appearance of endometrial carcinoma and mucinous cystadenoma in a postmenopausal patient treated with tamoxifen for breast cancer.
    Joja I; Asakawa T; Ando Y; Shiraiwa M; Shibutani O; Akaki S; Kuroda M; Mizutani Y; Kudo T; Hiraki Y
    Radiat Med; 1998; 16(4):315-9. PubMed ID: 9814431
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chemoprevention of breast cancer.
    Dalton RR; Kallab AM
    South Med J; 2001 Jan; 94(1):7-15. PubMed ID: 11213947
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Breast Cancer Prevention Trial takes off.
    Smigel K
    J Natl Cancer Inst; 1992 May; 84(9):669-70. PubMed ID: 1569598
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.